HYBRID - Visual Assessment of Treatment Response by using RECIP Criteria works well

被引:0
|
作者
Krome, Susanne
机构
关键词
D O I
10.1055/a-2191-6383
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The 177 Lu-PSMA therapy of previously treated prostate carcinomas requires careful monitoring in order to be able to adjust or discontinue treatments if necessary. The quantitative evaluation of the total tumor volume (TTV) from the PSMA-PET/CT using segmentation software was very reliable. However, its clinical implementation is not expected any time soon. The alternative qualitative evaluation by nuclear medicine experts showed a high level of agreement with the automated procedure.
引用
收藏
页码:342 / 343
页数:2
相关论文
共 50 条
  • [31] Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
    Delgado-Urena, Mayte
    Ortega, Francisco G.
    de Miguel-Perez, Diego
    Rodriguez-Martinez, Alba
    Garcia-Puche, Jose L.
    Ilyine, Hugh
    Lorente, Jose A.
    Exposito-Hernandez, Jose
    Carmen Garrido-Nayas, M.
    Delgado-Ramirez, Miguel
    Jose Serrano, M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [32] Composite assessment of treatment response in patients (pts) with locally advanced basal cell carcinoma (laBCC): Sonidegib efficacy using two sets of response criteria.
    Dummer, Reinhard
    Sondak, Vernon K.
    Grichnik, James M.
    Schwartz, Lawrence H.
    Gogov, Sven
    Yi, Tingting
    Mone, Manisha
    Trylesinski, Aldo
    Sellami, Dalila B.
    Migden, Michael Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Imaging After Locoregional Therapy for Hepatocellular Carcinoma With Emphasis on LIRADS Treatment Response Assessment Criteria
    Bajaj, Gitanjali
    Sundaram, Karthik
    Jambhekar, Kedar
    Ram, Roopa
    SEMINARS IN ULTRASOUND CT AND MRI, 2021, 42 (04) : 390 - 404
  • [34] [18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond
    Miceli, Alberto
    Jonghi-Lavarini, Lorenzo
    Santo, Giulia
    Cassarino, Gianluca
    Linguanti, Flavia
    Gazzilli, Maria
    Cimino, Alessandra
    Buschiazzo, Ambra
    Sorbello, Stefania
    Abenavoli, Elisabetta
    Conte, Miriam
    Pepponi, Miriam
    Di Dato, Rossella
    Rondini, Maria
    Salis, Roberto
    Tardelli, Elisa
    Nicolini, Denise
    Laudicella, Riccardo
    La Torre, Flavia
    Nappi, Anna Giulia
    CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (05) : 421 - 437
  • [35] Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
    Staber, Philipp B.
    Herling, Marco
    Bellido, Mar
    Jacobsen, Eric D.
    Davids, Matthew S.
    Kadia, Tapan Mahendra
    Shustov, Andrei
    Tournilhac, Olivier
    Bachy, Emmanuel
    Zaja, Francesco
    Porkka, Kimmo
    Hoermann, Gregor
    Simonitsch-Klupp, Ingrid
    Haferlach, Claudia
    Kubicek, Stefan
    Mayerhoefer, Marius E.
    Hopfinger, Georg
    Jaeger, Ulrich
    Dearden, Claire
    BLOOD, 2019, 134 (14) : 1132 - 1143
  • [36] [18F]FDG PET/CT criteria for treatment response assessment: EORTC and beyond
    Alberto Miceli
    Lorenzo Jonghi-Lavarini
    Giulia Santo
    Gianluca Cassarino
    Flavia Linguanti
    Maria Gazzilli
    Alessandra Cimino
    Ambra Buschiazzo
    Stefania Sorbello
    Elisabetta Abenavoli
    Miriam Conte
    Miriam Pepponi
    Rossella Di Dato
    Maria Rondini
    Roberto Salis
    Elisa Tardelli
    Denise Nicolini
    Riccardo Laudicella
    Flavia La Torre
    Anna Giulia Nappi
    Clinical and Translational Imaging, 2023, 11 : 421 - 437
  • [37] Accurate response assessment of breast cancer bone metastasis using computed tomography and new response criteria.
    Hamaoka, T
    Madewell, JE
    Costelloe, CM
    Islam, R
    Rondon, G
    Ayers, GD
    Champlin, RE
    Berry, DA
    Hortobagyi, GN
    Ueno, NT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 20S - 20S
  • [38] Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
    Gafita, Andrei
    Rauscher, Isabel
    Fendler, Wolfgang P.
    Murthy, Vishnu
    Hui, Wang
    Armstrong, Wesley R.
    Herrmann, Ken
    Weber, Wolfgang A.
    Calais, Jeremie
    Eiber, Matthias
    Weber, Manuel
    Benz, Matthias R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (12) : 4271 - 4281
  • [39] Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
    Andrei Gafita
    Isabel Rauscher
    Wolfgang P. Fendler
    Vishnu Murthy
    Wang Hui
    Wesley R. Armstrong
    Ken Herrmann
    Wolfgang A. Weber
    Jeremie Calais
    Matthias Eiber
    Manuel Weber
    Matthias R. Benz
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4271 - 4281
  • [40] Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression
    Huang, Raymond Y.
    Unadkat, Prashin
    Bi, Wenya Linda
    George, Elizabeth
    Preusser, Matthias
    McCracken, Jay D.
    Keen, Joseph R.
    Read, William L.
    Olson, Jeffrey J.
    Seystahl, Katharina
    Le Rhun, Emilie
    Roelcke, Ulrich
    Koeppen, Susanne
    Furtner, Julia
    Weller, Michael
    Raizer, Jeffrey J.
    Schiff, David
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2019, 21 (02) : 234 - 241